Safety and efficacy of an oral piperidine-based, reversible inhibitor of acetylcholinesterase in client-owned dogs with allergic skin disease
|Effective start/end date||6/1/20 → 9/30/22|
- NEURODERMA LLC
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.